RTTNews | Sep 7, 2021 08:35AM EDT

08:34 Tuesday, September 7, 2021 (RTTNews) - Horizon Therapeutics Begins Randomized Controlled Trial of TEPEZZA For Chronic (Inactive) Thyroid Eye Disease

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2021 RTTNews.com. All Rights Reserved